Monoclonal Gammopathy

Clinical Trials

Below is a list of Monoclonal Gammopathy clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

COX 2 Inhibitor (Celecoxib) for the Treatment of MGUS and Smoldering Myeloma (CN-25140)
This study is being done to find out what effects (good and bad) the drug Celecoxib (a nonsteroid anti-inflammatory drug) has on a patient and the patient's MGUS or Smoldering Myeloma.
Read more

Rituximab for Peripheral Neuropathy Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS)
Mayo Clinic Neurologists are trying a new approach to treat patients with neuropathy associated with paraproteinemia (also called MGUS neuropathy).

This medication shuts down abnormal antibody production by targeting a select type of antibody-producing lymphocytes in the bone marrow, leaving all other marrow cells alone.
Read more